Gastrointestinal stromal tumors: Differential diagnosis

被引:59
作者
Dow, Nancy
Giblen, Georgeta
Sobin, Leslie H.
Miettinen, Markku
机构
[1] Armed Forces Inst Pathol, Div Gastrointestinal Pathol, Washington, DC 20306 USA
[2] Armed Forces Inst Pathol, Div Soft Tissue Pathol, Washington, DC 20306 USA
关键词
GIST; differential diagnosis; KIT; PDGFRA; immunolhistochemistry; sarcoma; desmoid; inflammatory myofibroblastic tumor; melanoma;
D O I
10.1053/j.semdp.2006.09.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Availability of KIT tyrosine kinase inhibitors for specific treatment of GISTs has magnified the importance of accurate differential diagnosis of GIST from other tumors occurring in the GI tract and abdomen. The general problems in this distinction include histological mimicry of other mesenchymal tumors with GIST, occasional KIT-negativity of GIST, and KIT-positivity of non-GISTs. Up to 5% to 10% gastric GISTs and <2% of intestinal GISTs can be KIT-negative. The identification of these tumors as GISTs is based on knowledge of the spectrum of GIST morphology, and can be supported by molecular diagnosis of KIT and PDGFRA mutations (the latter pertain to gastric tumors). True smooth muscle tumors (rare in GI tract except in esophagus and colon) can be separated from GISTs by the eosinophilic tinctorial quality of tumor cells, positivity for smooth muscle markers, and negativity for KIT. Desmoids can form large GIST-like masses, but are composed of spindled or stellate-shaped cells in a densely collagenous stroma. Negativity for KIT and nuclear positivity for beta-catenin are differentiating features. GI schwannomas, melanoma, and rare primary clear cell sarcoma are S100-positive, usually with characteristic histology. The latter two can be KIT-positive. KIT-positive non-GISTs include some sarcomas, especially angiosarcoma and Ewing sarcoma, extramedullary myeloid tumor, seminoma, and a few carcinomas, notably small cell carcinoma of lung. Spurious KIT-positivity, seen with some polyclonal KIT antibodies, has been a source of confusion leading to probable false-positive results in fibroblastic tumors and occasional other sarcomas, such as leiomyosarcomas. Integration of histological features with carefully standardized immunohistochemistry, supported by KIT and PDGFRA mutation analysis, is the cornerstone of state-of-the art differential diagnosis of GIST. To comprehensively capture all GISTs, KIT immunostains should be performed on all unclassified epithelioid and mesenchymal tumors of the abdomen. This is a US government work. There are no restrictions on its use.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 69 条
[51]   Retroperitoneal leiomyomas - A clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas [J].
Paal, E ;
Miettinen, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (11) :1355-1363
[52]   Metanephric adenosarcoma in a young adult: Morphologic, immunophenotypic, ultrastructural, and fluorescence in situ hybridization analyses - A case report and review of the literature [J].
Picken, MM ;
Curry, JL ;
Lindgren, V ;
Clark, JI ;
Eble, JN .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (11) :1451-1457
[53]   c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells [J].
Ricotti, E ;
Fagioli, F ;
Garelli, E ;
Linari, C ;
Crescenzio, N ;
Horenstein, AL ;
Pistamiglio, P ;
Vai, S ;
Berger, M ;
di Montezemolo, LC ;
Madon, E ;
Basso, G .
BLOOD, 1998, 91 (07) :2397-2405
[54]   PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract [J].
Rossi, G ;
Valli, R ;
Bertolini, F ;
Marchioni, A ;
Cavazza, A ;
Mucciarini, C ;
Migaldi, M ;
Federico, M ;
Trentini, GP ;
Sgambato, A .
HISTOPATHOLOGY, 2005, 46 (05) :522-531
[55]  
Sarlomo-Rikala M, 1998, MODERN PATHOL, V11, P728
[56]   DUODENAL GANGLIOCYTIC PARAGANGLIOMA - CLINICOPATHOLOGICAL AND IMMUNOCYTOCHEMICAL STUDY OF 11 CASES [J].
SCHEITHAUER, BW ;
NORA, FE ;
LECHAGO, J ;
WICK, MR ;
CRAWFORD, BG ;
WEILAND, LH ;
CARNEY, JA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 86 (05) :559-565
[57]  
Shidham VB, 2002, ARCH PATHOL LAB MED, V126, P1189
[58]  
SHMOOKLER BM, 1982, AM J CLIN PATHOL, V77, P686
[59]   c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases [J].
Tamborini, E ;
Papini, D ;
Mezzelani, A ;
Riva, C ;
Azzarelli, A ;
Sozzi, G ;
Pierotti, MA ;
Pilotti, S .
BRITISH JOURNAL OF CANCER, 2001, 85 (03) :405-411
[60]   PERITONEAL LEIOMYOMATOSIS (LEIOMYOMATOSIS PERITONEALIS DISSEMINATA) - A CLINICOPATHOLOGIC STUDY OF 20 CASES WITH ULTRASTRUCTURAL OBSERVATIONS [J].
TAVASSOLI, FA ;
NORRIS, HJ .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1982, 1 (01) :59-74